The introduction of combination antiretroviral therapy (cART) led to a remarkable decline in epidemic KS incidence and a significant improvement in KS prognosis due to the rise in CD4 T-cell count and immune reconstitution [18,19,20]. Here, CD4 is linked to Kaposi's sarcoma.